Alternatively spliced tissue factor levels are elevated in the plasma of patients with chronic liver diseases-Reference-Cited by-同舟云学术

Alternatively spliced tissue factor levels are elevated in the plasma of patients with chronic liver diseases

Published:2018-12 Issue:12 Volume:30 Page:1470-1475
ISSN:0954-691X
Container-title:European Journal of Gastroenterology & Hepatology
language:en
Short-container-title:

Author:

Caversaccio Nathalie I.,Reina Caro Maria D.,Prince Raja,Müller Martin,Lewis Clayton S.,Bogdanov Vladimir Y.,Dufour Jean-François,Angelillo-Scherrer Anne

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Gastroenterology,Hepatology

Reference34 articles.

1. Effects of thromboxane A2 synthetase inhibitor on postischemic liver injury in rats;Kuroe;Eur Surg Res,199

2. Evidence of normal thrombin generation in cirrhosis despite abnormal conventional coagulation tests;Tripodi;Hepatology,2005

3. Von Willebrand factor deficiency reduces liver fibrosis in mice;Joshi;Toxicol Appl Pharmacol,2017

4. Factor VII activating protease (FSAP) exerts anti-inflammatory and anti-fibrotic effects in liver fibrosis in mice and men;Borkham-Kamphorst;J Hepatol,2013

5. Selective cellular expression of tissue factor in human tissues. Implications for disorders of hemostasis and thrombosis;Drake;Am J Pathol,1989

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Potential utility of a multi-component coagulation factor panel to calculate MELD scores and assess the risk of portal vein thrombosis in chronic liver disease;BMC Gastroenterology;2023-03-09

2. Potential utility of a multi-component coagulation factor panel to assess the risk of portal vein thrombosis in chronic liver disease;2022-09-30

3. Functional Characteristics and Regulated Expression of Alternatively Spliced Tissue Factor: An Update;Cancers;2021-09-16

4. Alternative RNA Splicing in Fatty Liver Disease;Frontiers in Endocrinology;2021-02-26